FDA seeking 'aggressive' adoption of AI . The FDA announced an "aggressive timeline" to deploy artificial intelligence ...

The Food and Drug Administration is going all in on artificial intelligence. | The Food and Drug Administration is going all ...

The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...

The FDA  plans to launch generative AI across all of its centers by June 30. The agency has also appointed its first chief AI ...

WASHINGTON — FDA Commissioner Martin Makary offered more details into the agency’s recently announced plans to place ...

The unintentional theme of today’s issue is the struggle for control over how we implement AI in the U.S. On one side, where ...

Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...

Q1 2025 Management View CEO Panna Sharma stated that "the first quarter of 2025 represents a pivotal inflection point for ...

GE HealthCare (Nasdaq: GEHC) today announced the launch of its CleaRecon DL technology for enhancing CBCT imaging.

The U.S. Food and Drug Administration (FDA) recently announced it plans to phase out animal testing in the development of monoclonal ...

The Food and Drug Administration plans to rapidly roll out a generative AI model to assist scientific ... encourage careful testing before full adoption. The announcement spurred many questions.